John Robert Faustino
Acute Care · Humble, TXNPI 1922734755
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,776 of the $4,584 with a category attached, or 60.6%. 24 manufacturers reported payments, led by Boston Scientific at 56.7% of the total. 2025 is the largest year on record at $3,245, more than ten times the $33 reported in 2022. Among acute care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $60.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Edwards Lifesciences$301
- Impulse Dynamics (USA) Inc.$294
- Actelion Pharmaceuticals US, Inc.$286
- Merck$168
- Novo Nordisk$145
- plus $791 from 18 others
What the payments were for
- Travel & lodging$1,71337%
- Food & beverage$2,77661%
- Education$952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $2,597 |
| Edwards Lifesciences | 2 | $301 |
| Impulse Dynamics (USA) Inc. | 4 | $294 |
| Actelion Pharmaceuticals US, Inc. | 4 | $286 |
| Merck | 9 | $168 |
| Novo Nordisk | 7 | $145 |
| Novartis | 4 | $100 |
| Amgen | 5 | $99 |
| Medtronic | 4 | $92 |
| Lexicon Pharmaceuticals, Inc. | 4 | $79 |
| Kestra Medical Technology Services, Inc. | 2 | $63 |
| Bridgebio Pharma, Inc. | 1 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Johnson & Johnson | 1 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $34 |
| AstraZeneca | 1 | $34 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Teleflex LLC | 1 | $25 |
| W. L. Gore & Associates, Inc. | 1 | $25 |
| Abbott | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| GSK | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,584 in reported general payments places this provider in the 90th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 15 | $262 |
| Metoprolol Succinate | 16 | $250 |
Paid to pharmacies, not to this prescriber.
Other acute care in Humble
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Bahia ElkamandSugar Land$23K
- Rachael SchneiderDallas$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.